Company: FENC
Filing Date: 2025-03-26
Form Type: 10-K
Source: 0001558370-25-003710
Chunk: 0

Company: FENNEC PHARMACEUTICALS INC.
Filing Date: 2025-03-26
Form: 10-K
Item: Item 10
Chunk 0
---
Item 10.      Directors, Executive Officers and Corporate Governance

The Company has an insider trading policy that governs the purchase, sale, and other dispositions of its securities by directors, officers, employees, and contractors, as well as by the Company itself. We believe that the insider trading policy is reasonably designed to promote compliance with insider trading laws, rules, and regulations and applicable listing standards. A copy of our insider trading policy is filed with this Annual Report on Form 10-K as Exhibit 19.

The remaining information required by this Item is incorporated herein by reference from our Proxy Statement for our 2025 Annual Meeting of Stockholders.

​